Therapeutic activation of IL-22-producing innate lymphoid cells enhances host defenses to Clostridioides difficile infection
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Kevin S Mears und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Interleukins, Clostridioides difficile, Immunity, Innate, Clostridium Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
- Department of Pathology, University of Pennsylvania Medical Center, Philadelphia, PA, USA.
- Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, New York, NY, USA.
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelph…
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- National Institute of Allergy and Infectious Diseases
- Israel National Road Safety Authority
- Abramson Cancer Center
Zitieren
APA
Mears, K. S., Denny, J. E., Maslanka, J. R., Mdluli, N. V., Hulit, E. N., Matsuda, R., Furth, E. E., Buffie, C. G., & Abt, M. C. (2025). Therapeutic activation of IL-22-producing innate lymphoid cells enhances host defenses to Clostridioides difficile infection. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115438
Vancouver
Mears KS, Denny JE, Maslanka JR, Mdluli NV, Hulit EN, Matsuda R, et al. Therapeutic activation of IL-22-producing innate lymphoid cells enhances host defenses to Clostridioides difficile infection. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115438
BibTeX
@article{Mears2025,
author = {Mears, Kevin S and Denny, Joshua E and Maslanka, Jeffrey R and Mdluli, Nontokozo V and Hulit, Ellie N and Matsuda, Rina and Furth, Emma E and Buffie, Charlie G and Abt, Michael C},
title = {Therapeutic activation of IL-22-producing innate lymphoid cells enhances host defenses to Clostridioides difficile infection},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115438}
}
EUVIMED